Company: PFSA
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001213900-25-044417
Chunk: 54

Company: Profusa, Inc.
Filing Date: 2025-05-15
Form: 424B3
Chunk 54
---
 no later than five business days prior to the special meeting. You may also obtain additional information about NorthView from documents filed with the SEC by following the instructions in the section entitled “ Where You Can Find More Information.” xxvii SUMMARY OF THE PROXY STATEMENT / PROSPECTUS This summary highlights selected information from this proxy statement / prospectus and does not contain all of the information that is important to you. To better understand the Business Combination and the proposals to be considered at the special meeting, you should read this entire proxy statement / prospectus carefully, including the annexes. See also the section entitled “Where You Can Find More Information.” Certain figures included in this section have been rounded for ease of presentation and, as a result, percentages may not sum to 100%. Parties to the Business Combination NorthView Acquisition Corporation NorthView is a blank check company formed in Delaware on April 19, 2021, for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, without limitation as to business, industry or sector. NorthView Common Stock, warrants and rights are currently quoted on OTC Pink under the symbols “NVAC,” “NVACW” and “NVACR,” respectively. The market value of the publicly traded common stock of NorthView on November 4, 2022, the last trading day preceding NorthView’s public announcement of the proposed business combination transaction was $9.98. NorthView’s warrants and rights did not trade on November 4, 2022. On December 22, 2021, NorthView consummated its initial public offering (“IPO”) of 18,975,000 units, including the issuance of 2,475,000 units as a result of the underwriters’ exercise of their over -allotmentoption in full. The units were sold at a price of $10.00 per unit, generating gross proceeds of $189,750,000. Simultaneously with the closing of the IPO, pursuant to certain subscription agreements, NorthView completed a private sale of an aggregate of 7,347,500 private placement warrants to NorthView’s sponsor, I -Bankers, and Dawson James (together, the “Representatives”) at a purchase price of $1.00 per private placement warrant, generating gross proceeds to the Company of $7,347,500. The private placement warrants are identical to the public warrants sold in the IPO except